Neuren Pharmaceuticals | NEU - Ordinary Share Capital



Neuren Pharmaceuticals reported AUD165.27M in Ordinary Share Capital for its fiscal semester ending in December of 2024.


Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2K 0 Dec/2024
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Genetic Signatures AUD 127.64M 8.22M Dec/2024
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Organon & Co USD 259.96M 256.96M Jun/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Tectonic Therapeutic USD 18.71M 18.71M Jun/2025
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024
Viatris USD 1.17B 1.15B Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025